PRMT5 and glioblastoma: Likewise, the combination of the PRMT5 inhibitor and LB100 (a protein phosphatase 2A (PP2A) inhibitor) enhanced G1 cell cycle arrest in glioblastoma cells (Otani et al., 2021).